Hebbar Sudarshan

CMO Hebbar Sudarshan purchases 9,563 shares of CALC at $2.82 on 2025-08-19, expanding stake by 18.4% amid -26.2% 30-day decline from peak.

Hebbar Sudarshan, Chief Medical Officer of CalciMedica, executed a buy of 9,563 shares at $2.82 on 2025-08-19, the third purchase within five days and expanding his post-transaction holdings to 61.5K shares (18.4% increase). The purchase occurs with the stock 47.4% below its 52-week high and down 26.2% over the prior 30 days, yet his same-ticker history shows 2 of 2 prior measurable buys were well-timed at the 90-day mark (43.5% and 99.3% gains 30-days out; 126.4% and 18.5% 90-days out). The company remains unprofitable with net income of -$6.0M, limiting the informational value of fundamental health, and the stock has risen 55.0% over 90 days despite the recent pullback. The repeated purchases in rapid succession and positive history at this specific ticker warrant tracking of whether this accumulation aligns with operational recovery or asset positioning.

Chief Medical Officer purchases 5,976 shares across 2 transactions for $16,361.50; holdings increase 13.0% to 52.0K shares.

Hebbar Sudarshan, Chief Medical Officer at CalciMedica, executed 2 separate purchases totaling 5,976 shares for $16,361.50, raising his total position from 46,000 to 51,976 shares (+13.0%). His cross-ticker track record shows 2 prior buys with an average 90d return of +72.4% and a 100.00% 90d win rate, and his prior trades at CALC specifically demonstrated well-timed accumulation (90d returns of +126.4% and +18.5%). The company's most recent full fiscal year reflected a net loss of $-5,956,000.00 against a market cap of $41,078,200.38, indicating an unprofitable business. The current share price of $2.94 sits 44.5% below the 52-week high of $5.30, having declined 2.3% over the past 30 days despite a 90-day advance of +58.1%. This purchase from a senior executive with a documented history of well-timed accumulation adds credibility to the recovery signal suggested by the recent three-month price movement.